{
    "organizations": [],
    "uuid": "77dc390082ec21786385d14a7da01a52482620e6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-melinta-therapeutics-announces-pro/brief-melinta-therapeutics-announces-proposed-offering-of-common-stock-idUSASC0A340",
    "ord_in_thread": 0,
    "title": "BRIEF-Melinta Therapeutics Announces Proposed Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 21 (Reuters) - Melinta Therapeutics, Inc.:\n* MELINTA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK\n* MELINTA THERAPEUTICS - COMMENCED UNDERWRITTEN PUBLIC OFFERING OF SHARES OF ITS COMMON STOCK TO RAISE AGGREGATE PROCEEDS OF APPROXIMATELY $75 MILLION\n* MELINTA THERAPEUTICS - INTENDS TO USE PROCEEDS FROM PROPOSED SALE OF ITS SHARES TO INVEST IN PORTFOLIO OF ANTIBIOTICS, AMONG OTHERS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T04:24:00.000+03:00",
    "crawled": "2018-05-22T19:27:41.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "melinta",
        "therapeutic",
        "melinta",
        "therapeutic",
        "announces",
        "proposed",
        "offering",
        "common",
        "stock",
        "melinta",
        "therapeutic",
        "commenced",
        "underwritten",
        "public",
        "offering",
        "share",
        "common",
        "stock",
        "raise",
        "aggregate",
        "proceeds",
        "approximately",
        "million",
        "melinta",
        "therapeutic",
        "intends",
        "use",
        "proceeds",
        "proposed",
        "sale",
        "share",
        "invest",
        "portfolio",
        "antibiotic",
        "among",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}